Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical Trials.

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical Trials.

Item
http://www.wikidata.org/entity/Q33890770
Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UKIncreased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?Pharmacokinetic drug evaluation of empagliflozin plus linagliptin for the treatment of type 2 diabetes.SGLT2 inhibitors: are they safe?Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.Cardiovascular outcomes with canagliflozin - is it on the CANVAS?Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor: Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real WEmpagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis.Cardiovascular effects of sodium glucose cotransporter 2 inhibitors.Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists.Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease - Implications for Clinical Practice
P2860

Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I-III Clinical Trials.

Item
http://www.wikidata.org/entity/Q33890770
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Safety and Tolerability of Emp ...... f Phase I-III Clinical Trials.
@ast
Safety and Tolerability of Emp ...... f Phase I-III Clinical Trials.
@en
type
label
Safety and Tolerability of Emp ...... f Phase I-III Clinical Trials.
@ast
Safety and Tolerability of Emp ...... f Phase I-III Clinical Trials.
@en
prefLabel
Safety and Tolerability of Emp ...... f Phase I-III Clinical Trials.
@ast
Safety and Tolerability of Emp ...... f Phase I-III Clinical Trials.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698
P921
P932
P356
P1433
P1476
Safety and Tolerability of Emp ...... of Phase I-III Clinical Trials
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698
P921
P932